The impact of vaginal surgical mesh devices on consultation rates by type and health care provider in UK primary care: A cohort study in the Clinical Practice Research Datalink

Pelvic mesh treats stress urinary incontinence (SUI) and pelvic organ prolapse (POP), although the therapeutic rationales involved are different. Its use has led to symptomatic improvements for some women, but this is not always the case. Its use has been subject to controversies, and in July 2018, the UK government announced a period of ‘high vigilance restrictions’ in its use to treat SUI and POP [1,2]. Complications of the procedure include pain, infection, depression, anxiety, sexual dysfunction, mesh erosion and further surgery [1,3–6].
Source: Maturitas - Category: Primary Care Authors: Tags: Original article Source Type: research